# A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.

> **NCT02174211** · NA · COMPLETED · sponsor: **King's College Hospital NHS Trust** · enrollment: 59 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** Ranibizumab
- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT02174211
- **Lead sponsor:** King's College Hospital NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2021-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02174211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02174211, "A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02174211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*